Entrada Therapeutics, Inc. (TRDA)Healthcare | Biotechnology | Boston, United States | NasdaqGM
7.00 USD
-0.27
(-3.714%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 7.00 |
Hot Take ↕ | Aug. 22, 2026, 5:13 a.m. EDT
Entrada Therapeutics presents a classic value trap scenario where the market has correctly priced out the business despite optimistic analyst targets. The company is hemorrhaging cash with massive negative free cash flow and a 54% drop in revenue year-over-year, while returning capital to insiders via executive sales. The price action confirms this deterioration, having lost over half its value in just three years and trading well below its 200-day average. Although the beta is negative, suggesting a defensive correlation, the fundamental reality is a failing biotech with no revenue growth and a shrinking balance sheet. The options market agrees with the pessimism, with heavy put positioning capping any potential rally. There is no margin of safety here; the stock is simply too far gone to recover without a miraculous clinical success that hasn't materialized yet. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.066450 |
| AutoETS | 0.070363 |
| AutoARIMA | 0.070364 |
| MSTL | 0.096351 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 1.17 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.338 |
| Excess Kurtosis | -1.05 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 20.798 |
| Revenue per Share | 0.112 |
| Market Cap | 272,556,672 |
| Forward P/E | -2.23 |
| Beta | -0.26 |
| Website | https://www.entradatx.com |
As of Aug. 22, 2026, 5:13 a.m. EDT: Speculators are positioning defensively with heavy put open interest at the $10 strike, creating a significant barrier for upside. While there is some call volume at higher strikes ($12.50, $15.00), the overwhelming Open Interest concentration in the downside suggests a 'bear put spread' mentality rather than a bullish breakout attempt. Implied volatility is elevated on puts relative to calls, indicating fear of further downside following the recent trial data miss.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.35130107 |
| Address1 | One Design Center Place |
| Address2 | Suite 17- 500 |
| All Time High | 36.85 |
| All Time Low | 4.93 |
| Ask | 8.87 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 212,580 |
| Average Daily Volume3 Month | 349,843 |
| Average Volume | 349,843 |
| Average Volume10Days | 212,580 |
| Beta | -0.257 |
| Bid | 5.21 |
| Bid Size | 2 |
| Board Risk | 4 |
| Book Value | 7.517 |
| City | Boston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.0 |
| Current Ratio | 10.889 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 7.24 |
| Day Low | 6.94 |
| Debt To Equity | 20.798 |
| Display Name | Entrada Therapeutics |
| Earnings Timestamp | 1,785,933,000 |
| Earnings Timestamp End | 1,793,881,800 |
| Earnings Timestamp Start | 1,793,881,800 |
| Ebitda | -170,863,008 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.456 |
| Enterprise To Revenue | 16.632 |
| Enterprise Value | 77,937,888 |
| Eps Current Year | -3.66333 |
| Eps Forward | -3.13857 |
| Eps Trailing Twelve Months | -3.81 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.0682 |
| Fifty Day Average Change | -0.06820011 |
| Fifty Day Average Change Percent | -0.009648865 |
| Fifty Two Week Change Percent | 35.130108 |
| Fifty Two Week High | 16.45 |
| Fifty Two Week High Change | -9.450001 |
| Fifty Two Week High Change Percent | -0.5744681 |
| Fifty Two Week Low | 5.02 |
| Fifty Two Week Low Change | 1.98 |
| Fifty Two Week Low Change Percent | 0.39442232 |
| Fifty Two Week Range | 5.02 - 16.45 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,635,514,200,000 |
| Float Shares | 23,995,562 |
| Forward Eps | -3.13857 |
| Forward P E | -2.230315 |
| Free Cashflow | -77,671,624 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 152 |
| Fullday Change | -0.27 |
| Fullday Change Percent | -3.71389 |
| Fullday Price | 7.0 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Gross Profits | -134,355,008 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.122729994 |
| Held Percent Institutions | 0.83198 |
| Implied Shares Outstanding | 38,936,669 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-29 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. |
| Long Name | Entrada Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 272,556,672 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_595472652 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -165,778,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 283,069,583 |
| Number Of Analyst Opinions | 4 |
| Open | 7.18 |
| Operating Cashflow | -134,674,000 |
| Operating Margins | -50.07016 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 857 520 9158 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 7.0 |
| Post Market Time | 1,787,947,805 |
| Previous Close | 7.27 |
| Price Eps Current Year | -1.9108298 |
| Price Hint | 2 |
| Price To Book | 0.93122256 |
| Price To Sales Trailing12 Months | 58.164036 |
| Profit Margins | 0.0 |
| Quick Ratio | 10.515 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.27 |
| Regular Market Change Percent | -3.71389 |
| Regular Market Day High | 7.24 |
| Regular Market Day Low | 6.94 |
| Regular Market Day Range | 6.94 - 7.24 |
| Regular Market Open | 7.18 |
| Regular Market Previous Close | 7.27 |
| Regular Market Price | 7.0 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 111,601 |
| Return On Assets | -0.29195 |
| Return On Equity | -0.54095 |
| Revenue Growth | -0.539 |
| Revenue Per Share | 0.112 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 38,936,669 |
| Shares Percent Shares Out | 0.0608 |
| Shares Short | 2,367,019 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,230,697 |
| Short Name | Entrada Therapeutics, Inc. |
| Short Percent Of Float | 0.0943 |
| Short Ratio | 5.45 |
| Source Interval | 15 |
| State | MA |
| Symbol | TRDA |
| Target High Price | 25.0 |
| Target Low Price | 11.0 |
| Target Mean Price | 19.0 |
| Target Median Price | 20.0 |
| Total Cash | 223,004,992 |
| Total Cash Per Share | 6.185 |
| Total Debt | 48,544,000 |
| Total Revenue | 4,686,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.81 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 9.701775 |
| Two Hundred Day Average Change | -2.7017746 |
| Two Hundred Day Average Change Percent | -0.27848253 |
| Type Disp | Equity |
| Volume | 111,601 |
| Website | https://www.entradatx.com |
| Zip | 2,210 |